Showing results (581-590 of 659) with videos related to

Sort By:
Pageof 66
The Lancet. Microbe|February 22, 2026
Bedaquiline resistance in patients with Xpert MTB/RIF Ultra-tested rifampicin-resistant tuberculosis in the Western Cape, South Africa: a prospective studyJanré Steyn, Jennifer Williams, Fahd Naufal, et al.
The Lancet. Microbe|January 21, 2023
First-in-human use of a modular capsid virus-like vaccine platform: an open-label, non-randomised, phase 1 clinical trial of the SARS-CoV-2 vaccine ABNCoV2Merel J Smit, Adam F Sander, Maud B P A Ariaans, et al.
The Lancet. Microbe|March 10, 2023
Mpox respiratory transmission: the state of the evidenceAmy Beeson, Ashley Styczynski, Christina L Hutson, et al.
The Lancet. Microbe|March 17, 2023
International manufacturing and trade in colistin, its implications in colistin resistance and One Health global policies: a microbiological, economic, and anthropological studyMuhammad Umair, Brekhna Hassan, Refath Farzana, et al.
The Lancet. Microbe|April 12, 2021
Reporting practices for genomic epidemiology of tuberculosis: a systematic review of the literature using STROME-ID guidelines as a benchmarkBrianna Cheng, Marcel A Behr, Benjamin P Howden, et al.
The Lancet. Microbe|April 16, 2023
Hybrid immunity against reinfection with SARS-CoV-2 following a previous SARS-CoV-2 infection and single dose of the BNT162b2 vaccine in children and adolescents: a target trial emulationSivan Gazit, Yaki Saciuk, Galit Perez, et al.
The Lancet. Microbe|February 9, 2026
Parasite clearance in patients with Plasmodium vivax monoinfection treated with artesunate in Cambodia: an observational secondary analysis of trial dataKieran Tebben, Virak Eng, Dynang Seng, et al.
The Lancet. Microbe|February 8, 2026
Characterisation of Trichuris incognita n sp in Côte d'Ivoire: a morphological, genomic, and genome-wide association with drug sensitivity studyMax Alexander Bär, Nadège Akissi Kouamé, Sadikou Touré, et al.
The Lancet. Microbe|January 25, 2026
Emerging terbinafine-resistant Trichophyton indotineae between 2018 and 2023: a multinational genomic epidemiology studyJohanna Rhodes, Sui Ting Hui, Sarah Dellière, et al.
The Lancet. Microbe|January 30, 2026
Artesunate-pyronaridine-atovaquone-proguanil and artesunate-fosmidomycin-clindamycin compared with standard artesunate-pyronaridine for the treatment of uncomplicated malaria (MultiMal): a randomised, controlled, clinical, phase 2 trial in Gabon and GhanaJean Claude Dejon Agobé, Oumou Maïga-Ascofaré, Ayôla Akim Adegnika, et al.
Pageof 66